Compare JRSH & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JRSH | CSBR |
|---|---|---|
| Founded | 2016 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 81.0M |
| IPO Year | 2017 | 2015 |
| Metric | JRSH | CSBR |
|---|---|---|
| Price | $5.82 | $4.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 79.8K | 11.9K |
| Earning Date | 02-09-2026 | 03-12-2026 |
| Dividend Yield | ★ 5.68% | N/A |
| EPS Growth | ★ 485.71 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $166,263,870.00 | $2,900,000.00 |
| Revenue This Year | $11.64 | $4.84 |
| Revenue Next Year | $10.06 | $11.51 |
| P/E Ratio | $45.38 | ★ N/A |
| Revenue Growth | ★ 14.03 | N/A |
| 52 Week Low | $2.85 | $4.59 |
| 52 Week High | $5.97 | $8.31 |
| Indicator | JRSH | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 60.95 | 48.35 |
| Support Level | $3.01 | $4.71 |
| Resistance Level | $5.81 | $6.31 |
| Average True Range (ATR) | 0.22 | 0.27 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 83.50 | 42.86 |
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.